IMC Chicago’s iPath Series B S&P 500 VIX Mid-Term Futures ETN VXZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-67,341
Closed -$3.88M 3927
2025
Q2
$3.94M Buy
67,341
+10,105
+18% +$610K ﹤0.01% 1554
2025
Q1
$3.16M Buy
57,236
+20,507
+56% +$1.07M ﹤0.01% 1498
2024
Q4
$1.86M Buy
+36,729
New +$1.87M ﹤0.01% 1926
2024
Q3
Sell
-6,730
Closed -$335K 3074
2024
Q2
$335K Buy
+6,730
New +$348K ﹤0.01% 2447
2022
Q3
Sell
-49,829
Closed -$5.96M 1297
2022
Q2
$5.96M Buy
49,829
+21,330
+75% +$2.47M 0.01% 527
2022
Q1
$3.02M Buy
+28,499
New +$3.04M ﹤0.01% 667
2021
Q3
Sell
-10,333
Closed -$1.06M 1306
2021
Q2
$1.06M Hold
10,333
﹤0.01% 903
2021
Q1
$1.2M Hold
10,333
﹤0.01% 826
2020
Q4
$1.27M Hold
10,333
﹤0.01% 806
2020
Q3
$1.41M Hold
10,333
﹤0.01% 654
2020
Q2
$1.39M Sell
10,333
-3,069
-23% -$411K ﹤0.01% 641
2020
Q1
$1.71M Sell
13,402
-12,014
-47% -$1.03M ﹤0.01% 530
2019
Q4
$1.81M Buy
+25,416
New +$1.91M ﹤0.01% 543

Other funds holding VXZ

IMC Chicago's VXZ Position: Q3 2025 in Review

IMC Chicago sold out of iPath Series B S&P 500 VIX Mid-Term Futures ETN (VXZ) in Q3 2025, closing a stake of 67,341 shares — an estimated $3.88M sold.

IMC Chicago first reported a position in VXZ in Q4 2019 and held it in 13 quarters. The position peaked at $5.96M in Q2 2022. 8 funds tracked by Wall St. Rank hold VXZ as of Q3 2025.

  • IMC Chicago reported no remaining iPath Series B S&P 500 VIX Mid-Term Futures ETN position as of Q3 2025 after selling out during the quarter.
  • IMC Chicago sold 67,341 iPath Series B S&P 500 VIX Mid-Term Futures ETN shares in Q3 2025, an estimated $3.88M.
  • IMC Chicago first reported a position in iPath Series B S&P 500 VIX Mid-Term Futures ETN in Q4 2019 and held it in 13 quarters.
  • IMC Chicago's iPath Series B S&P 500 VIX Mid-Term Futures ETN position peaked at $5.96M in Q2 2022.
  • 8 funds tracked by Wall St. Rank held iPath Series B S&P 500 VIX Mid-Term Futures ETN as of Q3 2025.

Based on IMC Chicago's 13F filing for Q3 2025, filed 4 Nov 2025.